1. Merck Patent Gmbh (9 from 2,943 patents)

2. Merck Patent Gesellschaft MIT Beschrankter Haftung (3 from 1,248 patents)

3. Merck Patent Gesellschaft MIT Beschraenkter Haftung (1 from 100 patents)

1. 9233937 - Method of stimulating insulin secretion and/or modulating INS-1 kinase with substituted pyrazinones and/or substituted tetrahydroquinoxalinones

2. 9102632 - Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes

3. 8835634 - Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes

4. 8815859 - Substituted pyrazin-2-ones and substituted 5,6,7,8-tetrahydroquinoxalin-2-ones and methods of use thereof

5. 8673955 - Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them

6. 8642617 - Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes

7. 8637522 - Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes

8. 8609689 - Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes

9. 8415352 - Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes

10. 8362057 - Imidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same

11. 8232272 - Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same

12. 8178556 - Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes

13. 7816397 - Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes